Theriva Biologics closes $2.5M public offering of shares and warrants

Theriva Biologics, Inc.

Aggregate gross proceeds of approximately $2.5 million from offering of common shares and warrants.
Pricing at $1.75 per share and accompanying warrant; warrants exercisable at $2.00 per share for five years.
Post-offering outstanding shares: 2,272,462; proceeds for working capital, R&D, and manufacturing scale-up.
A.G.P./Alliance Global Partners served as placement agent with 7% fee plus expense reimbursement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.